Takeda Pharmaceutical (TAK) Other Non-Current Liabilities (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded Other Non-Current Liabilities of $731.27 million in the quarter ended Jun 30, 2026, up 18.7% from $615.93 million a year earlier and up 14.9% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical reported Other Non-Current Liabilities of $663.11 million, up 21.9% from the prior year.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 4.3% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Other Non-Current Liabilities came in at $543.96 million in the year ended Mar 31, 2025 (-3.1%), $561.23 million in the year ended Mar 31, 2024 (+16.0%), $484.02 million in the year ended Mar 31, 2023 (-19.2%) and $598.67 million in the year ended Mar 31, 2022 (+11.5%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Other Non-Current Liabilities in data going back to the quarter ended Mar 31, 2018.
- On a year-over-year basis, Other Non-Current Liabilities has increased for five consecutive quarters, with growth averaging 11.6% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 18.7% in the quarter ended Jun 30, 2026, against a decline of 14.5% in the quarter ended Mar 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $636.49 million (quarter ended Mar 31, 2026), $626.87 million (quarter ended Dec 31, 2025) and $607.6 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 731.27 Mn |
| Mar 31, 2026 | 636.49 Mn |
| Dec 31, 2025 | 626.87 Mn |
| Sep 30, 2025 | 607.60 Mn |
| Jun 30, 2025 | 615.93 Mn |
| Mar 31, 2025 | 543.11 Mn |
| Dec 31, 2024 | 571.67 Mn |
| Sep 30, 2024 | 543.77 Mn |
| Jun 30, 2024 | 563.59 Mn |
| Mar 31, 2024 | 546.15 Mn |
| Dec 31, 2023 | 490.30 Mn |
| Sep 30, 2023 | 494.09 Mn |
| Jun 30, 2023 | 529.84 Mn |
| Mar 31, 2023 | 494.34 Mn |
| Dec 31, 2022 | 472.13 Mn |
| Sep 30, 2022 | 509.02 Mn |
| Jun 30, 2022 | 563.06 Mn |
| Mar 31, 2022 | 578.37 Mn |
| Jun 30, 2021 | 536.85 Mn |
| Mar 31, 2021 | 537.54 Mn |
API Access
Takeda Pharmaceutical Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();